UNRESECTABLE BREAST CANCER
Clinical trials for UNRESECTABLE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE BREAST CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study tracks how a targeted drug stacks up against chemo for Hard-to-Treat breast cancer
Disease control Recruiting nowThis study follows over 1,100 adults with HER2-low breast cancer that cannot be removed by surgery or has spread. Researchers will compare how long patients stay on trastuzumab deruxtecan (a targeted drug) versus standard chemotherapy before needing a new treatment. The goal is t…
Matched conditions: UNRESECTABLE BREAST CANCER
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for Hard-to-Treat breast cancer: drug duo targets rare mutation
Disease control Recruiting nowThis study tests a combination of two drugs, tucatinib and trastuzumab, in people with a specific type of advanced breast cancer that has a mutation in the HER3 gene. The cancer must be HER2-negative and has already been treated with at least two prior chemotherapies. The goal is…
Matched conditions: UNRESECTABLE BREAST CANCER
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Blood test could help personalize breast cancer therapy
Disease control Recruiting nowThis study tests whether a blood test measuring thymidine kinase activity (TKa) can help doctors decide early if a patient's breast cancer treatment is working. Patients with HR+ HER2- metastatic breast cancer start standard therapy with a CDK4/6 inhibitor and endocrine therapy. …
Matched conditions: UNRESECTABLE BREAST CANCER
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC